PT1274408E - Utilizacao de compostos naturais de crisantona tendo actividade antiangiogenica - Google Patents

Utilizacao de compostos naturais de crisantona tendo actividade antiangiogenica

Info

Publication number
PT1274408E
PT1274408E PT01917464T PT01917464T PT1274408E PT 1274408 E PT1274408 E PT 1274408E PT 01917464 T PT01917464 T PT 01917464T PT 01917464 T PT01917464 T PT 01917464T PT 1274408 E PT1274408 E PT 1274408E
Authority
PT
Portugal
Prior art keywords
crisantona
utilization
natural compounds
antiangiogenic activity
chrysanthone
Prior art date
Application number
PT01917464T
Other languages
English (en)
Inventor
Penco Sergio
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT1274408E publication Critical patent/PT1274408E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
PT01917464T 2000-03-13 2001-03-12 Utilizacao de compostos naturais de crisantona tendo actividade antiangiogenica PT1274408E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000128A IT1317000B1 (it) 2000-03-13 2000-03-13 Uso di composti di origine naturale ad attivita' antiangiogenica.

Publications (1)

Publication Number Publication Date
PT1274408E true PT1274408E (pt) 2005-03-31

Family

ID=11454525

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01917464T PT1274408E (pt) 2000-03-13 2001-03-12 Utilizacao de compostos naturais de crisantona tendo actividade antiangiogenica

Country Status (17)

Country Link
US (1) US6887883B2 (pt)
EP (1) EP1274408B1 (pt)
JP (1) JP2004500395A (pt)
KR (1) KR20020081420A (pt)
AT (1) ATE285230T1 (pt)
AU (1) AU2001244537A1 (pt)
CA (1) CA2401267A1 (pt)
CZ (1) CZ20022761A3 (pt)
DE (1) DE60107942T2 (pt)
ES (1) ES2234827T3 (pt)
HU (1) HUP0302472A2 (pt)
IT (1) IT1317000B1 (pt)
MX (1) MXPA02008952A (pt)
PL (1) PL356931A1 (pt)
PT (1) PT1274408E (pt)
SK (1) SK11882002A3 (pt)
WO (1) WO2001068071A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101094157B1 (ko) 2011-04-04 2011-12-14 임세규 식물생약재를 이용한 당뇨개선용 건강보조식품

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843755A (en) * 1996-05-20 1998-12-01 Ajinomoto Co., Inc. Group of antitumor compounds and method for producing the same
JP2002520367A (ja) * 1998-07-14 2002-07-09 ブリストル−マイヤーズ スクイブ カンパニー アンギオスタチンのリジン結合フラグメント

Also Published As

Publication number Publication date
ATE285230T1 (de) 2005-01-15
AU2001244537A1 (en) 2001-09-24
CA2401267A1 (en) 2001-09-20
CZ20022761A3 (cs) 2003-03-12
ITRM20000128A0 (it) 2000-03-13
DE60107942T2 (de) 2005-12-08
ES2234827T3 (es) 2005-07-01
PL356931A1 (pl) 2004-07-12
US6887883B2 (en) 2005-05-03
US20030149068A1 (en) 2003-08-07
WO2001068071A2 (en) 2001-09-20
WO2001068071A3 (en) 2002-06-06
SK11882002A3 (sk) 2003-02-04
MXPA02008952A (es) 2003-04-25
HUP0302472A2 (hu) 2003-12-29
ITRM20000128A1 (it) 2001-09-13
EP1274408A2 (en) 2003-01-15
IT1317000B1 (it) 2003-05-26
DE60107942D1 (de) 2005-01-27
KR20020081420A (ko) 2002-10-26
EP1274408B1 (en) 2004-12-22
JP2004500395A (ja) 2004-01-08

Similar Documents

Publication Publication Date Title
DE60009511D1 (de) Nematizide trifluorbutene
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO20003233L (no) 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler
TR200100672T2 (tr) Yeni izoksazolinon antibakteriyel ajanları
ATE403429T1 (de) Spiropyrazol-verbindungen
NO983688L (no) Serin-protease-inhibitorer
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
ATE365730T1 (de) Neuartige verbindungen
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
DK1305037T3 (da) Smertestillende medikament
NO20014240D0 (no) C16-umettede FP-selektive prostaglandinanaloger
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
IL146543A0 (en) Inhibitors of metalloproteinases
DK1204659T3 (da) Serotonerge benzofuraner
BR0115996A (pt) Sulfamidotienopirimidinas
NO20032406L (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
ECSP003761A (es) Compuestos heterociclicos sililados
AU2001244537A1 (en) Use of natural compounds having antiangiogenic activity
ID27733A (id) Metoksiminofenilasetamida
TR200003084T2 (tr) Paroxetine askorbat
DE69909097D1 (de) 5-bicycloindolverbindungen
PT1220844E (pt) Derivados de benzimidazole substituidos como arilssulfonamida e sua utilizacao como inibidores de triptase
SE9901340D0 (sv) Novel process